ARCHIVES

Tamoxifin Benefits Outweigh Risks, NSABP Study Finds

This article is from The Cancer Letter archive.

Vol. 20 No. 12 | March 23, 1994

Download PDF Visit The Full Archive

Related Articles

NEJM Papers Reaffirm Results Of Lumpectomy Trial; Audit Verifies Data

December 8, 1995

NIGMS Hosts Meeting On Increasing Minorities In Biomedical Careers

December 1, 1995

Fox Chase Publishes Its Cancer Survival Data

February 4, 2011

DCPC Concepts Approved

September 27, 1985

HHS Secretary Rebukes Task Force Guidelines On Breast Cancer Screening

November 29, 2009

Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival

December 27, 2013